Results 201 to 210 of about 20,957 (246)
Correction: <i>In Vitro</i> BBB triculture assay and preliminary computational model development to predict brain exposure. [PDF]
Front ToxicolXu ZM, Sluka JP, Zhang CC, Knipp G.
europepmc +1 more source
Accessibility to antimalarials in Spanish hospitals: analysis of a national survey. [PDF]
Malar JBretones-Pedrinaci JI +4 more
europepmc +1 more source
Are basic and lipophilic chain groups highly required in leishmanicidal quinolines to favor the phagolysosome accumulation? [PDF]
Front ChemRomero AH.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Journal of Parasitology, 1992
A bioassay method that allows for the estimation of serum concentrations of mefloquine is presented. Concentrations obtained by bioassay and high performance liquid chromatography showed a good correlation. This bioassay should be helpful in assessing prophylactic/treatment failures to mefloquine under field conditions.
A E, Yeo, K H, Rieckmann
openaire +2 more sources
A bioassay method that allows for the estimation of serum concentrations of mefloquine is presented. Concentrations obtained by bioassay and high performance liquid chromatography showed a good correlation. This bioassay should be helpful in assessing prophylactic/treatment failures to mefloquine under field conditions.
A E, Yeo, K H, Rieckmann
openaire +2 more sources
Reactions Weekly, 2000
Abstract Mefloquine is a quinoline-methanol derivative developed at the U.S. Walter Reed Army Institute of Research for treament of drug-resistant malaria, particularly chloroquineresistant Plasmodium falciparum malaria. The mechanism of action is unknown.
openaire +2 more sources
Abstract Mefloquine is a quinoline-methanol derivative developed at the U.S. Walter Reed Army Institute of Research for treament of drug-resistant malaria, particularly chloroquineresistant Plasmodium falciparum malaria. The mechanism of action is unknown.
openaire +2 more sources